Concepedia

Publication | Open Access

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma

326

Citations

24

References

2020

Year

Abstract

ClinicalTrials.gov Identifier: NCT02919683.

References

YearCitations

Page 1